These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30138859)

  • 1. The relationship between serum cytokine levels and degree of psychosis in patients with schizophrenia.
    Dahan S; Bragazzi NL; Yogev A; Bar-Gad M; Barak V; Amital H; Amital D
    Psychiatry Res; 2018 Oct; 268():467-472. PubMed ID: 30138859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.
    Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY
    Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder.
    Hope S; Ueland T; Steen NE; Dieset I; Lorentzen S; Berg AO; Agartz I; Aukrust P; Andreassen OA
    Schizophr Res; 2013 Apr; 145(1-3):36-42. PubMed ID: 23403415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia.
    O'Brien SM; Scully P; Dinan TG
    Psychiatry Res; 2008 Sep; 160(3):256-62. PubMed ID: 18722671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse.
    Borovcanin M; Jovanovic I; Radosavljevic G; Djukic Dejanovic S; Bankovic D; Arsenijevic N; Lukic ML
    J Psychiatr Res; 2012 Nov; 46(11):1421-6. PubMed ID: 22974591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
    Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
    Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SERUM CYTOKINE CONCENTRATIONS ASSOCIATION WITH THE SEVERITY OF SYMPTOMS IN MAJOR DEPRESSION].
    Madi Y; Yogev A; Bar-Gad M; Amital H; Barak V; Amital D
    Harefuah; 2017 Dec; 156(12):753-756. PubMed ID: 29292611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.
    Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC
    Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology.
    Xiu MH; Chen DC; Wang D; Zhang K; Dong A; Tang W; Zhang F; Liu LJ; Liu JH; Liu HB; Yang FD; Kosten TR; Zhang XY
    J Psychiatr Res; 2012 Aug; 46(8):1093-8. PubMed ID: 22647522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
    Sirota P; Meiman M; Herschko R; Bessler H
    Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation.
    Al-Hakeim HK; Al-Rammahi DA; Al-Dujaili AH
    J Affect Disord; 2015 Aug; 182():106-14. PubMed ID: 25985379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides.
    Pawlaczyk M; Sobieska M
    Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):107-12. PubMed ID: 17053844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers.
    Fan N; Luo Y; Xu K; Zhang M; Ke X; Huang X; Ding Y; Wang D; Ning Y; Deng X; He H
    Schizophr Res; 2015 Dec; 169(1-3):10-15. PubMed ID: 26589393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder.
    Boerrigter D; Weickert TW; Lenroot R; O'Donnell M; Galletly C; Liu D; Burgess M; Cadiz R; Jacomb I; Catts VS; Fillman SG; Weickert CS
    J Neuroinflammation; 2017 Sep; 14(1):188. PubMed ID: 28923068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
    Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms.
    Stojanovic A; Martorell L; Montalvo I; Ortega L; Monseny R; Vilella E; Labad J
    Psychoneuroendocrinology; 2014 Mar; 41():23-32. PubMed ID: 24495605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine profile in drug-naïve, first episode patients with psychosis.
    Petrikis P; Voulgari PV; Tzallas AT; Archimandriti DT; Skapinakis P; Mavreas V
    J Psychosom Res; 2015 Oct; 79(4):324-7. PubMed ID: 26213351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.